CDE accepts the application for consistency evaluation of phenobarbital tablets
Good news keeps coming. In May 2021, CDE accepted our company's application for consistency evaluation of phenobarbital tablets, which is another piece of good news after our company received the news of CDE accepting the application for apixaban tablets at the end of April.
The acceptance of the application for phenobarbital tablets is a powerful proof of our company's overall ability to take it to the next level Our company will continue to maintain a fighting attitude and overcome difficulties with the spirit of time waits for no one.
